IMO, this is a positive result and statistically significant.
The results are not groundbreaking and that was NOT expected by those who underestand the clinical aspect of the game, and for those who have some understanding of the the market, this is no disappointment (sorry if others who expected to be instant billionaires are disappointed - adds to their other concerns in this crisis).
We are on the right track and the track as hoped.
Those who ultimately decide on the value of this stock are the big guns, not a retail trader selling/buying a relatively small floating shares in retail hands.
Ann: Immutep reports supportive efficacy data from AIPAC study, page-13
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.010(3.08%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.0¢ | $584.2K | 1.787M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 311433 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 113721 | 6 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |